A comprehensive review of nearly 154,000 participants has upended one of geriatric medicine’s most entrenched assumptions: that routine calcium and vitamin D supplementation protects older adults from fractures and falls. The meta-analysis, published in The BMJ and drawing on 69 randomised controlled trials, found that taking calcium, vitamin D, or a combination of the two provided no clinically meaningful reduction in fracture risk or fall incidence for the vast majority of elderly people. Viewed from research hubs in Europe and North America, the findings strike at the heart of public health strategies that have long promoted these supplements as a simple, low-cost safeguard against the bone fragility and loss of independence that accompany ageing.

Yet the picture is not one of outright futility. German nutrition experts, writing in the Bild newspaper, caution that a silent epidemic of vitamin D deficiency persists across northern latitudes, where sun exposure is insufficient for much of the year. Many individuals, they note, mistakenly believe that time spent outdoors obviates the need for supplementation, unaware that modern indoor lifestyles and seasonal darkness leave them chronically depleted. Vitamin D, they argue, remains essential for calcium absorption, muscle strength, and immune function—roles that the BMJ review does not dismiss, even if supplementation alone fails to prevent fractures in a general elderly population.

In Iran and Indonesia, coverage of the same review has been accompanied by a parallel conversation about the subtler warning signs of calcium deficiency. Tehran-based health outlets have catalogued five often-overlooked symptoms: muscle cramps and spasms, tingling in the extremities, dental decay, dry skin and brittle nails, and heart palpitations. These reports underscore that calcium’s role extends far beyond bone density, encompassing nerve transmission, blood clotting, and hormonal secretion. The Indonesian press, meanwhile, has framed the BMJ findings as a wake-up call for families caring for ageing relatives, noting that falls remain a leading cause of long-term disability in Southeast Asia’s rapidly greying societies.

Adding further nuance, Persian-language analyses have explored the distinct contributions of magnesium and vitamin D to immunity and energy metabolism. Magnesium, they observe, supports immune cells and helps regulate inflammation, while vitamin D modulates the body’s defence against respiratory infections. Neither mineral is a panacea for fracture prevention, but their broader physiological importance suggests that blanket dismissal of supplementation would be premature. The challenge for clinicians is to move beyond one-size-fits-all prescribing and toward targeted testing and dietary counselling.

Looking ahead, the review is likely to accelerate a shift already underway in geriatric guidelines, away from universal supplementation and toward personalised risk assessment. Health systems from Berlin to Jakarta will need to weigh the cost of mass programmes against the evidence that they do not reduce fractures, while still addressing genuine deficiencies that can impair quality of life. The debate is no longer whether calcium and vitamin D matter—they plainly do—but how best to deliver them in a world where a pill alone cannot keep bones intact.